Non-alcoholic fatty liver disease (NAFLD) has a prevalence of 7–10% among children in the developed world, making it the most common cause of chronic liver disease in this population. Its prevalence is rising concomitant with the rise in obesity.1 NAFLD incorporates a spectrum of liver abnormalities, ranging from simple steatosis, to, non-alcoholic steatohepatitis (NASH), involving various degrees of inflammation, ballooning and fibrosis. NASH may evolve into cirrhosis, accounting for its place as the second most common listing indication for adult liver transplantation (LT) in the United States.1 It is vital to intervene in the paediatric population to avert this outcome.
展开▼
